Some oral cancers are preceded by premalignant lesions which include l
eucoplakia and erythroplakia. At present there are no reliable markers
to identify lesions that may progress to malignancy. We have analysed
30 potentially malignant oral lesions for deletions at chromosomal re
gions that harbour tumour-suppressor genes for oral cancer. A total of
16 of 30 cases (53%) showed loss of heterozygosity (LOH) or allele im
balance at TP53, DCC, 3p21.3-22.1 or 3p12.1-13. These genetic alterati
ons were detected in dysplastic lesions but not in histologically norm
al mucosa and may be early events in the carcinogenic process. A total
of 64% of dysplastic lesions that recurred during the study showed LO
H or allele imbalance in the initial biopsy and the number of genetic
abnormalities increased in the tumours that developed. This type of mo
lecular profiling may help to identify patients with lesions that may
recur or acquire additional genetic events and progress to malignancy.